キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/02/26 | 2,937 | 2,981 | 2,937 | 2,949 | +33 | +1.1% | 72,700 |
2018/02/23 | 2,911 | 2,923 | 2,899 | 2,916 | +15 | +0.5% | 42,700 |
2018/02/22 | 2,858 | 2,910 | 2,850 | 2,901 | +32 | +1.1% | 84,200 |
2018/02/21 | 2,898 | 2,907 | 2,866 | 2,869 | -48 | -1.6% | 38,600 |
2018/02/20 | 2,914 | 2,927 | 2,896 | 2,917 | +2 | +0.1% | 35,700 |
2018/02/19 | 2,883 | 2,915 | 2,883 | 2,915 | +75 | +2.6% | 39,700 |
2018/02/16 | 2,855 | 2,900 | 2,833 | 2,840 | +12 | +0.4% | 68,500 |
2018/02/15 | 2,781 | 2,844 | 2,755 | 2,828 | +77 | +2.8% | 120,100 |
2018/02/14 | 2,791 | 2,804 | 2,741 | 2,751 | -40 | -1.4% | 90,900 |
2018/02/13 | 2,860 | 2,869 | 2,780 | 2,791 | +2 | +0.1% | 196,700 |
2018/02/09 | 2,798 | 2,811 | 2,771 | 2,789 | -56 | -2% | 106,800 |
2018/02/08 | 2,870 | 2,898 | 2,838 | 2,845 | -25 | -0.9% | 120,200 |
2018/02/07 | 2,826 | 2,930 | 2,826 | 2,870 | +70 | +2.5% | 132,900 |
2018/02/06 | 2,800 | 2,840 | 2,748 | 2,800 | -84 | -2.9% | 194,700 |
2018/02/05 | 2,948 | 2,970 | 2,877 | 2,884 | -102 | -3.4% | 149,100 |
2018/02/02 | 2,973 | 2,994 | 2,948 | 2,986 | +1 | ±0% | 100,200 |
2018/02/01 | 3,075 | 3,085 | 2,971 | 2,985 | -100 | -3.2% | 194,400 |
2018/01/31 | 3,150 | 3,180 | 3,080 | 3,085 | -65 | -2.1% | 109,900 |
2018/01/30 | 3,195 | 3,205 | 3,150 | 3,150 | -55 | -1.7% | 58,000 |
2018/01/29 | 3,215 | 3,255 | 3,205 | 3,205 | -10 | -0.3% | 51,800 |
2018/01/26 | 3,160 | 3,220 | 3,155 | 3,215 | +55 | +1.7% | 72,300 |
2018/01/25 | 3,210 | 3,220 | 3,155 | 3,160 | -50 | -1.6% | 55,000 |
2018/01/24 | 3,185 | 3,220 | 3,180 | 3,210 | +25 | +0.8% | 40,200 |
2018/01/23 | 3,185 | 3,205 | 3,180 | 3,185 | +15 | +0.5% | 46,800 |
2018/01/22 | 3,170 | 3,170 | 3,145 | 3,170 | -20 | -0.6% | 59,400 |
2018/01/19 | 3,195 | 3,205 | 3,165 | 3,190 | -5 | -0.2% | 64,400 |
2018/01/18 | 3,250 | 3,270 | 3,190 | 3,195 | ±0 | ±0% | 90,800 |
2018/01/17 | 3,200 | 3,210 | 3,185 | 3,195 | -30 | -0.9% | 53,300 |
2018/01/16 | 3,245 | 3,255 | 3,220 | 3,225 | -30 | -0.9% | 52,600 |
2018/01/15 | 3,250 | 3,275 | 3,240 | 3,255 | +30 | +0.9% | 41,900 |
2018/01/12 | 3,340 | 3,350 | 3,215 | 3,225 | -130 | -3.9% | 102,600 |
2018/01/11 | 3,345 | 3,360 | 3,325 | 3,355 | ±0 | ±0% | 44,800 |
2018/01/10 | 3,310 | 3,355 | 3,310 | 3,355 | +30 | +0.9% | 39,600 |
2018/01/09 | 3,335 | 3,335 | 3,305 | 3,325 | -10 | -0.3% | 52,000 |
2018/01/05 | 3,330 | 3,345 | 3,295 | 3,335 | +15 | +0.5% | 57,600 |
2018/01/04 | 3,250 | 3,330 | 3,215 | 3,320 | +125 | +3.9% | 64,700 |
2017/12/29 | 3,195 | 3,215 | 3,180 | 3,195 | ±0 | ±0% | 27,800 |
2017/12/28 | 3,205 | 3,220 | 3,190 | 3,195 | -10 | -0.3% | 36,800 |
2017/12/27 | 3,245 | 3,245 | 3,195 | 3,205 | -30 | -0.9% | 23,000 |
2017/12/26 | 3,240 | 3,250 | 3,230 | 3,235 | -15 | -0.5% | 46,900 |
2017/12/25 | 3,235 | 3,250 | 3,225 | 3,250 | +20 | +0.6% | 54,100 |
2017/12/22 | 3,210 | 3,230 | 3,195 | 3,230 | +10 | +0.3% | 50,500 |
2017/12/21 | 3,205 | 3,235 | 3,195 | 3,220 | +5 | +0.2% | 42,000 |
2017/12/20 | 3,220 | 3,220 | 3,180 | 3,215 | -25 | -0.8% | 72,000 |
2017/12/19 | 3,235 | 3,250 | 3,230 | 3,240 | +5 | +0.2% | 38,600 |
2017/12/18 | 3,240 | 3,245 | 3,210 | 3,235 | +20 | +0.6% | 70,900 |
2017/12/15 | 3,205 | 3,215 | 3,175 | 3,215 | +25 | +0.8% | 110,200 |
2017/12/14 | 3,170 | 3,205 | 3,155 | 3,190 | +40 | +1.3% | 97,000 |
2017/12/13 | 3,185 | 3,185 | 3,135 | 3,150 | -15 | -0.5% | 125,100 |
2017/12/12 | 3,170 | 3,185 | 3,150 | 3,165 | ±0 | ±0% | 55,100 |
1651~
1700
件表示中 / 3589件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 363,000円 | +14.5% | -2.3% | 2.48% | 13.28倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
住友ファーマ | 60,300円 | +7.5% | - | 0.00% | - | 2.10倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 429,000円 | +22.8% | +113.0% | 4.43% | 11.44倍 | 1.05倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 295,300円 | +52.1% | +23.3% | 0.00% | 20.97倍 | 4.02倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
東和薬品 | 277,000円 | +15.0% | -7.3% | 2.17% | 9.09倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム